Functional informatics drug discovery (17 Ergebnisse)

Paperback. Zustand: New. Brand new book, sourced directly from publisher. Dispatch time is 7-8 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: New. 2019. 1st Edition. paperback. . . . . .

Paperback. Zustand: Brand New. 160 pages. 9.21x6.14x0.36 inches. In Stock.

Zustand: New. 2019. 1st Edition. paperback. . . . . . Books ship from the US and Ireland.

Zustand: New. Sergey IlyinIntegrating various technologies with informational systems provides vast improvements to the overall research and development that occur in the biopharmaceutical industry. One of the first books to explore this area, Functional Infor.

Paperback. Zustand: new. Paperback. Integrating various technologies with informational systems provides vast improvements to the overall research and development that occur in the biopharmaceutical industry. One of the first books to explore this area, Functional Informatics in Drug Discovery examines all aspects of technology integration and information flow in a biopharmaceutical enterprise and outlines the specific technologies used at various stages of drug development. With contributions from leaders in academia, information technology, and the pharmaceutical industry, each chapter illustrates how a particular area of biological science can benefit from the tools of informatics. The book first looks at intelligent automation, neurally based computational tools, and pharmacodynamic (PD) biomarkers. It then reviews a variety of novel technologies and approaches presently used in drug discovery at Johnson & Johnson. The text also describes how informatics can advance antibody technology and drug development for oncology. After focusing on forward genetic and reverse genetic strategies to identify relevant target genes for drug discovery, the book explains proteomic expression profiling and explores the application of laser microdissection in transcriptomics.Taking a systematic approach, this volume examines the impact of informatics tools on various areas in biopharmaceuticals by presenting in-depth analyses of emerging trends and future opportunities.Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry. This volume examines the impact of informatics tools on various areas in biopharmaceuticals by presenting in-depth analyses of emerging trends and future opportunities. It presents automation approaches for collecting and analyzing biological data and explains how to use PD biomarkers to accelerate drug development. The book also reviews a variety Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.…

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Gebunden. Zustand: New. Ilyin, SergeyIntegrating various technologies with informational systems provides vast improvements to the overall research and development that occur in the biopharmaceutical industry. One of the first books to explore this area, Functional Info.

Hardcover. Zustand: Brand New. 1st edition. 146 pages. 9.50x6.50x0.50 inches. In Stock.

Zustand: New. pp. xii + 146.

Buch. Zustand: Neu. Neuware - This volume examines the impact of informatics tools on various areas in biopharmaceuticals by presenting in-depth analyses of emerging trends and future opportunities. It presents automation approaches for collecting and analyzing biological data and explains how to use PD biomarkers to accelerate drug development. The book also reviews a variety of novel drug discovery approaches presently used at Johnson & Johnson, and discusses the clinical successes of antibody therapeutics for treating oncology cases. In addition, it offers an integrated approach to identify relevant target genes for drug discovery and explores the application of laser microdissection in transcriptomics.…